Compare ADMA Biologics Inc (ADMA) vs American Express Co (AXP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs American Express Co — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while American Express Co trades at $340.05 (market cap $230.15B). The key difference: American Express Co is far larger — about 103.7× ADMA Biologics Inc's market cap, and American Express Co pays a 1.11% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AXP | |
|---|---|---|
Market Cap | $2.22B | $230.15B |
Sector | Health | Financials |
52-Week High | $20.38 | $384.82 |
52-Week Low | $7.60 | $292.27 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 1.11% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About American Express Co
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →
